Raymond James Financial Services Advisors’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-20,830
Closed -$123K 3314
2022
Q3
$123K Buy
+20,830
New +$123K ﹤0.01% 2952